| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 11. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | etanercept (Benepali®) |
| Formulation | 50 mg/1ml solution for injection |
| Reference number | 3022 |
| Indication | For the full licensed indication to include rheumatoid arthritis/psoriatic arthritis/axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)/plaque psoriasis |
| Company | Biogen Idec Ltd |
| BNF chapter | Musculoskeletal & joint diseases |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 02/02/2016 |